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Familial Colorectal Cancer Type-X (FCCTX) is a syndrome defined by criteria
with a strong family historyofCRC R,:5 cases ofCRC) of unknown gencticctiology,
families originated from multiple different geographic isolates. The use ofacustomized
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lIST OF ABBREVIATIONS
SEER: Surveillance, Epidemiology, and End Results
(Lichtenstein et al.,2000). The lifetime risk of developing coloreetaIcancer(CRC)asa
memberofthegenera1populationisapproximately6~7%(Greenetal.,2007).It is the
third most prevalent form ofcancer in Canada, following breast and prostatecancer,
comprising approximately 13%ofall cases ofcancer as well as the second leadingcause
ofcancer deaths (Canadian Cancer Society,2010). Despitc having a relativelylow
incidence of cancers of all types, the Newfoundland population demonstratesthehighest
incidence mteofCRC in the country (Canadian Cancer Society. 2010). Risk factors for
the devclopment ofCRC include high consumption of red meat (Sandhu et al.. 2001;
Nomtetal.,2(02)andalcohol(Longneckeretal.,I990),cigarettesmoking(Giovannucci
and Martinez, 1996),high body mass index (Russoet aI., 1998),sedentarylifestyIe,
diabetcs(LeMarchandetal.,I997),familyhistoryofCRC(Fuchsetal.,l994),ahistory
ofinOammatory bowel diseasc (Bemstein et al.,2001). a history of colorectalpolyps
(Vogclsteinetal.,1988),hereditarysyndromewithapredispositiontoCRC(Burkeetal.,
1997),and old age (Tumeretal., 1999). The advances in ourunderstanding of human
genetics coupled with an increascd emphasis on preventive medicine makesthe
identification of individuals with high predisposition toCRC ahigh priority and nn
A comprehensive 1itemture search of numerous relevant medical databases
(Pubmed, EM BASE. The Cochrane Library, Biological Abstmcts. Biomedical Reference
Collection, CINAHL,Clinical Evidence. PILOTS Database,Proquest, SciFinderScholar,
polyposiscolorectalcancer.....microsatelliteinstability.....genetics". "screening",
surveyed to identify additional literature on topics of interest
Neoplasia is the process ofabnonnal cellular growth and proliferation caused by
gene mUlationsthatcan result in tumour fonnation. CRC occurs as a result of the process
of neoplasia, which replacesnonnal colonic epithelium with adenocarcinoma cell5
(Grady. 2006). The majority of mutations that promote tumour formation are somatic
Germline mutations in genes associated with cancer susceptibility are responsibleonly
for conferring increased risk for, and not directly causing. tumour fonnation (Marsh and
Zori.2002).Knudson'stwo-hithypothesisproposesthatbothcopiesofaparticular
tumour suppressor gene must be mutated for carcinogenesis to occur (Knudson, 1971)
Thus. carcinogenesis is much more likc1y in the scltingofa germline mutationasonly
one subsequent somatic mutation is required. On the other hand. sporadie neoplasia
requires two scparate somatic mutatlons to both copies ofthc gene (Jackson, 1985)
These variants confer cclls with survival advantages and arc thus able tohyperproliferatc
within the developing tumour (Nowell. 1976). Somatic mutations in genesinvolvedinthe
WinglcssIWnt,RAS-RAF-MAPK,phosphatidylinositoI3-kinase.andTGF-psignaling
pathways are the most common genetic alterations in the process ofcolorectal tumour
formation (Grady, 2006). CRCstend to arise from the inactivation of tumour suppressor
genes combined with activation of oncogenes via mutation accumulation(Fearonand
Vogelstein,I990).lntheirclassicreviewofcolorcctaltumourigenesis.VogelsteinetaJ
proposed a roughly scquentiaJ model for the mutations involved in tumourigenesis
initiating with a mutation in theadenomatous polyposis coli (APC) gene folIowedbythe
acquisition of mutations in KRASandp53 (Vogelstein et al.. 1988). However,more
recent investigations have emphasized the heterogeneity and complexity of the somatic
mutations that are accumulated in the process of tumour development (Wood etal.,
Prior to the 1990s, the adenomatous polyp and the hyperplastic polyp were the
onlytwoclassificationsofcolonicepithelialpolyps,areasoftissueextending into the
lumen of the colon (Songet al.. 2007; Noffsinger, 2009). The malignant potentiaJofthe
traditional adenoma has long been recognized. Theadenoma-carcinomasequence.wruch
fonnsthebasisofourunderstandingofcolorectaltumourigenesis,proposcdthat
colorectaltumoursdeveiopfromprecursoradenomas(Morson,1962;Vogelstein et aI.,
1988; Bond,2003;Cappell,2007). Hyperplastic polyps are typically small in size and
occur more frequently in the distal colon (Cappell and Forde, 1989).Theyarepresentin
approximalelyI25%ofasymptomaticadultsovertheageofSO(Lieberman et al.,2000)
They have been classically viewed as lesions with minimal neoplastic potentialand
therefore as insignificant findings (Morson, 1962; Arthur, 1968; Williamsetal.,1980).
This nOlion has bcenre-evaluated more recently with support for the viewthataJl
hyperplastic polyps have malignant potential (Jass. 1999). The finding of colorectal
tumours in mixed hyperplastic adenomatous polyps (Urbanski etal., 1984) and the strong
associationofhypcrplastic polyposis, a condition of multiple hyperplasticpolyps.with
CRCservedassupportingevidenceforthisproposal(Jeevaratnametal.,J996)
hyperplasticadenomatous polyps that did not fit neatly intoeitherofthe two
classifications (Longacre and FenoglicrPreiser, J990).The epithelium of these polyps
had the serrated characler typical of hyperplastic polyps, but Ihe atypical finding of an
appreciable grade of dysplasia (Hawkinset al., 2002). Themalignant potential of these
polyps has been well described in the literature with oneslUdy reporting 5.8%of
randomlyselectedcolorectaltumoursbeingassociatedwithadjacentserratedadenomas
(Makinen et al.,200J). However, it has been shown that the serrated adenomahasa
lowermaJignantpotentialthanthetraditionaladenomatouspolyp(Songetal.,2(07).It
hasbeenproposedthatthis'serratedneoplasiapathway'represenlSadifferentbiological
pathway to CRC from the traditional adenoma-carcinoma sequence (Hawkins et aI.,
ResearchhasuncoveredfourmainmolecularpalhwaystoCRCemphasizingthe
heterogeneity of the process. Our understanding of the nature of these palhwaysis
continually evolving as the complex web ofcarcinogenesis is gradually elucidated. The
two main pathways are microsatellite instability (MSl) and chromosomalinstability.Both
of these processes result in genomic instability,akey underlying mechanism 0 fcolorectal
tumourigenesis(Stoleretal..I999).Morerecentlyathirdnovelpalhwayhasbccn
proposed,knownasthe serrated pathway. Lastly is the familialcolorcclal cancertypcx
(FCCTX) classification, which isa blanket term to encompass a heterogeneous group
wilh similar phenotypes who cannot be classified by currently understood hercditary
predisposition mechanisms. It is plausible that this classification encompasses several
molecular pathways to CRC. It is also lhoughtthat right· and lefi-sidedcolorectal
tumours may evolve from distinct biological pathways. Left·sidedCRC i5 more common
in males and middJe·aged patients. while right·sided CRC is more frequentinfemales
The model ofVogelsteinet al. was built around the idea that most colorectal
tumours developed from precursor adenomas vialhe adenoma·carcinoma sequence
(Mor>on, 1962; Vogelstein el aI., 1988; Bond, 2003; Cappell, 2007). Italsocenteredon
the notion of chromosomal instability as the molecular mechanism leading toCRCasa
(Young and Jass. 2006). Chromosomal instability produces genomic instability via
changes in chromosomal copy number and structure. This phenomenon ischaracterized
byaneuploidyandlossofheterozygosity(Lengaueretal.,I998).lnvesligationsutilizing
comparative genomic hybridization havedemonstraled that specific areasof
chromosomal gains and losses are associated with theadenoma-ca rcinomasequence
(Meijerelal,I998;Hemlsenetal.,2002).Tumourdevelopmenlinfamilialadenomatous
polyposis (FAP) occurs via chromosomal instability (Lindor, 2009). This istheresultof
aneuploid and polyploid chromosomal alterations that occur at lhe stan 0 ftheadenoma-
carcinoma sequence due to theAPC mutation (Alberici and Fodde,2006).
lenglh of repeat units from thegermline microsatellite allelc (De laChapelle. 2003). The
reference panel for lhe detection ofMSI consists of five validated microsatellitemarkers
panel (Boland et aI., I99S). A lumour is labeled MSI-hiSh(MSI-H) if two or more of the
five markers show instability, MSI·low(MSI-L) if only one of the markers shows
instability. and microsatellitc stable (MSS) if none of the markers show instability
(Boland et al.. 1998). However, when none of the markers show instability one cannot
exclude the MSI·L classification with the use of only five markers (Halford et aI., 2002).
CRCs arc generally subdivided based on thc presence or absence ofMSI. However,there
investigators grouping thiscategol)' together with MSS(Laihoct al. ,2002).whileothcrs
contend that MSI-L should be treated asa separate category and may represent a distinct
pathway to carcinogenesis (Jass et aI., 2002; Rudzkietal.,2003; Bapat etal.,2009)
mutations, but also occurs in approximately 15% of sporadic cases ofCRC (Halfordet
al.,2002).SomaticbiallelicinactivationofMLHJbypromoterhypermethylationhas
been shown to be the C3Use of the MSI in lhese sporadic cases (Veigl et aI., 1998;
'·icrmanetal., 1998; Cunningham et ai., 1998). Adeciine in lhe exprcssionofMLHlhas
also bcen associated with increasing age, thereby making the clderly more susceptibleto
sporadiccasesofCRCdemonstratingMSI (Kakaretal..2003). MSI is also thoughtto
playa role in the development ofother cancers. such as sporadic cases ofendometrial
cancer (Sobczuk et al.,2007) and oral squamous cell carcinoma (Sanguansinet a1.,2006)
inconsistcnt. Two separate papers published in 2005 assessed difTercnces in clinical
significantly reduced risk of death in individuals with MSI-H DNA compared to those
withMSSDNAwithrespectivehazardratiosofO.46(95%CI:0.31-0.68)andO.65
(95%CI: 0.59-0.71) (Benatti etal.,2005; Popatetal.,2005). The study ofBenattietal
wasretrospectiveinnature,buthadalargesamplesizeofCRCpatients(N=1263),used
one uniform measure ofMSI (the Bethesda panel),and controlled confounding variables
via multivariate analysis. On the other hand. Popatetal. conducted a mela-analysis of
thirty-two trials (N = 7,642) that suffers from a [ailurcto [omlallyassessthe quality of
included trials as well as heterogeneity between included studies in terms of general
protocol and in the groupingofMSI-L and MSS. The mechanisms underlying the
prognosticadvantageofMSlhaveyettobeestablished,butitislikelythatothcrfcatures
thatdifTcrbctwcenthcMSI and MSS pathways undcrlic the prognosticdiffcrcnce
resemblance 10 hyperplastic polyps (Jasset aI., 1992).Theprecursor lesions for this type
oflumourarethehyperplasticpolyp,thetraditionalserraledadenoma.and the sessile
serrated adenoma (forlakovicet al.,2003: Noffsinger. 2009). This serrated pathway has
been subdivided into one pathway leading to MSI-H CRC and theotherto MSI-LCRC
H CRC (Noffsinger, 2009). They demonstrate a high frequency of somalicactivating
mutations in the proto-oncogene and serine/threonine kinase BRAF,theCpGisland
methylator phenotype (CIMP),variable levels of MSI,and an increased frequencyof
right-sided lumours(Youngetal.,2005; Wish et aJ., 2010). On theotherhand,the
Irnditional serrated adenoma appears to be a precusorto MSS or MSI-LCRC that is more
frequently left-sided,demonslrntes a CLMP-Iow phenotype. and containspredominantly
KRASmutationsratherthanBRAF( offsinger,2009;LeggenandWhitehall,2010).The
CIMPischaracterizedbyaberrantDNAmethylationresultinginhypemlethylationof
KRASand BRAFare oncogenes that are involved in signaling with the
RasIRapMEKIERKIMAPKpathway(Figurel.I).lthasbeenhypothesizedthal
deleterious variants in the BRAFand KRASgenes have equivalent effeelSon
tumourigenesis (Storm and Rapp, 1993). Somatieallyacquired KRAS variants have been
shown to bea key event in the transformation and further growth of sma11 adenomas,
which isavilal step in progression in the adenoma-carcinoma sequence (Yogelstein et
al.,1988).Thus,itappearsthatsomaticBRAFdeleleriousvariants play a similarly
important role in coloreclal carcinogenesis. The p.YaI6OOGlu BRAFvariant
(c.1799T>A),accounling for 80% of BRAF variation, directly causes constitutive
activation oflhe RASIRAFIM£KI£RKfMAPK pathway (Davies et aL,2002). On the other
hand,the less common BRAFvariant require the concurrent presenceofaRASvarianlin
orderloactivatethepathway.ltisthoughtthatcausalvariantsinthe oncogenes BRAF
and KRASresuit in allered regulation of the cell eycleand hyperproliferation of cells
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Figurel.l:RoleofKRASandBRAFintheRaslRaflMEKIERKIMAPKsignaling
pathway. Adapted from Leggeuand Whitehall (2010)
KRASand BRAFactivate MEK which phosphorylates and activates extracellularsignal-
regulated kinase (ERK),which translocates into the nucleus to alter expression of cell
all casesofCRCvary between 5% and 18%, with thep.Val6OOGlu variantaccountingfor
Rajagopalanetal,2002:Yuenetal.,2002:SamowilZetal .. 2005).Repol1edrat'esofthe
p.Val6OOGluBRAFvariantin patientswithMSI in the lileratureare 16%,45%. and 52%
(Domingoetal .• 2004: Lubomierski etal .• 2005:SamowilZetal.,2005).On!heother
hand. only 5% ofMSS tumours have been shown to have the p.Val6OOGluBRAFvariant
and these individuals have been shown to have a poorer prognosis (Lubomierskietal_.
2005; Samowitzet al .• 2005). BRAF variants are associated with the somatic inactivation
ofMUIlbyCIMP-associatedhypennethylation,theetiologyoftheI5%ofsporadic
cases ofCRC that are MMR-deficient.and not with gennlineinheritanceofMLHI
deleterious variants (Wang et al., 2003: Domingoet al .• 2004; Weisenbergeretal.,2006)
Family history is the most predictive risk factor for the deve!opmentofCRCwith
approximately 35% of cases being influenced by geneticsusceptibilityfactors
(Lichtenstein et aI., 2000). The inherited fonns ofCRC have been shown to be the result
of germline mutations in mismatch repair (MMR) genes, APC, SMAD4, STKIIILKBI,
MlffYH. and BMPRIA (Aahonen et al.. 2007). The two most common forms of inherited
CRC, both characterized by autosomal dominant inheritance, are hereditary non-
polyposiscolorectal cancer (HNPCC), also known as Lynch syndrome. and familial
adenomatouspolyposis(FAP).lndividualswithFAPhaveaninheritedgerm-line
mutation in APC resuhing in the formation of numerous adenomatous polyps.which
iscausedbyinheritedorgcnnlinevariantsintheMMRsystem(Boland,2005). This
system is responsible for repairing errors that occur during DNA replicationinvolving
incorrect nucleotide matclllng(Aquilinaand Bignami,2001).Carriersofmutations in the
MMR genes are at approximately an SOOIo lifetime risk for developing CRC (Mecklinand
Jarvinen, 2005). Othersyndromic forms ofCRC include juvenile polyposis(causedby
SMAD4andBMPRIAmutations),PeulZ-Jegherlisyndrome(causedbySTKIIILKBI
mutationsJ,and MUTYH-associated polyposis (Aaltoncn et aI., 2(07). Recent genome•
susceptibility loci, which are contributing factors towards hereditary risk ofCRC
(Houlstonetal.,200S).Toaccount for these newly discovered and currently unknown
loci, a new genetic susceptibility syndrome has bcen described,known as Familial
ColoreclalCancerType-X(FCCTX).Lndividualswiththissyndromeof\enmcetthe
diagnostic criteria for HNPCC, although the condition has a fundamentally different, and
currently unknown, geneticetio!ogy. Intennsofnomenclature, itis morc appropriate to
use the !abcl "Lynch Syndromc" for individuals with a gcnnlinc MMRdelctcrious
diagnosticcritcriaforHNPCC,thcArnsterdamI (ACI)(Abdcl·Rahman andPeltomaki,
1.5.1 Hereditary Non-PolyposisColorectal Cancer (HNPCC) and Lynch Syndrome
HNPCC was firlit described by Warthin in 1913 (Warthin, 1913) and then by
Lynchmorethanfiftyyearslater(Lynchetal.,I966).ltischaracterizedbyautosomal
dominantinheritaoce.highpe:netrance,variableexpressivity,earlyageofonset, right·
(Stucklesset aJ.. 2007). Additionally, the incidenceofextra-colonic cancers of the
stomach. endometrium. ovaries, pancreas, small bowel. brain, and tmnsitionalcellsofthe
renal pelvis and ureter, as well as sebaceous tumours is increased (AnayaetaL,2oo8).In
classic cases of Lynch Syndrome, the autosomal dominant inheritance and high
penetranceofthediseaseresultsinupto500loofrelativesinsuccessivegenerations being
affected by CRC or one of the aforementioned extra-colonic cancers (Vasen. 2007).
Defects in the MMR system have been identified as the cause of Lynch Syndrome
(Aquilina and Bignami. 2001). Mutations in MSH2, MLH/. MSH6, and PMSl are
responsibleforapproximately95%ofmutationsresuhinginHNPCC(Woodset8I.,
2005). Individuals with Lynch Syndrome experience multiple errors in repetitiveDNA
sequences called microsatellites within their MMR-deficient tumours. This fundamental
changcinthestructureoftheirDNAistennedMSlandischaracteristicofLynch
Syndrome(BapatctaJ.,1999).MSIistheresultofthcfailureofthcMMRsystem to
repair mismatched nucleotidesfolJowing DNA replic8tion resulting in contraction or
expansion of short nucleotide sequences between one and four base pairs in length (Ward
A significant number of individuals who mcet the diagnostic criteria for HNPCC
actually have microsatellite stable (MSS) DNA and lack agennline MMR gene mutation
According to recent literature. approximately 500/ooftheindividuals who meet the
stringcntACIfallintothiscategory(LindoretaJ..2005;L1oretal.,2005).102005,
Lindoret aL proposed that the label "Familial Colorectal Cancer Type X" (FCCTX) be
testing allows families meeting the Amsterdam Criteria to be properly c1assifiedaseither
LynchSyndromeorFCCTX,withtheexceptionoftheI5%ofspomdictumours
displayingMMRdeficiencyasaresultofMLHlhypermethylationratherthan
inheritance ofa germline MMRdeleterious variant (Hennan et al., 1998). The tenn
FCCTXcncompassesfamiliesdisplayingapanemofCRCconsistentwithautosomal
Afrasiabi, 2007). The genetic basis forFCcrx remains to be elucidated and it is
hypothesized that novel susceptibility genes exist, mutations to which predispose
individuals to the development ofCRC (Woods et aI., 2005). However, it Iikely
encompasses multiple fonnsofhereditary CRCofunknown genetic eliology (Woodset
al.,2010). As novel susceptibility genes arc discovered. additional categoriesof
hcrcditary CRC can be established and the definition of FCCTX can be adjusted
Recent literaturc suggests that the phenotype of FCCTX is significantIyless
scvercthanthatofLynchSyndrome.Jassetal.perfonnedthcfirstdireClcomparison of
the phenotype of individuals meeting the ACI with lumoursthat wereeitherMSSorMSI
(Jassetal.,1995).ThcmainlimitationofthestudywasthesmallsampIe size in the MSI
(N =62) and MSS(N = 17) groups being compared. The MSS group had a later mean age
ofonsct ofcancer (54 years) than the MSI group(48years),significantly fewer cases of
multiple cancers, and more instances ofaneuploidy. Anolher invesligation also reports
this tendency of MSS tumours to demonstrate aneuploidy, while this rarely occurs in MSI
tumours. which demonstrate almost exclusively diploidy (Albericiand Fodde, 2006)
which repon that colorectal tumours tend to be right-sided in Lynch Syndrome,while
those of FCCTX are more frequently left-sided (Renkonen et aI., 2003; L10ret a1., 2005)
Lindoretal.undenookastudyofcancerincidencesinI6IAClpedigrees(N=
3422) divided into two groups: I.) MSI-H and MMRdeleterious variant (Lynch
Syndrome group), 2.) MSI-L or MSS with no MMR deleterious variant (FCCTX group)
(Lindoret aI., 2(05). The limitations of this investigation are its retrospective nature and
the fact that it groups MSI-L and MSS together rather than considering them
independently. The authors used standardized incidence ratios (SIRs) as their measure of
risk, which compares the incidenceofanevent in the study population relativet03
nonnal population. Thenonnal population was derived from the SEER9database,which
is a cancer registry for various regions of the United States between 1973 and 2007. The
FCCTX group demonstrated a significant increased incidence ofCRC (SIR 2.3, 95% CI
1.7-3.0) relative to this nonnal population. On the other hand,the Lynch Syndrome
groupexpcriencedasignificantlygrcaterincidenccofCRC(SIR6.1,95%CI:5.2-7.2)
andofextra-coloniccancersofthestomach,urinarytract,smallintestine, endometrium
and ovary. Thus, the riskofCRC in the FCCTX group was less than halfofthat of the
Lynch Syndrome group without significant risk for any extra-colonic cancers
Additionally, cases ofCRC in FCCTX families tended to have aconsiderablylateronset
than for individuals with Lynch Syndrome. The mean age ofdiagnosis ofCRCwas
significantly (p < 0.05) earlier in relatives of the Lynch Syndrome group (48.7 years)
versus the FCCTX group (60.7 years). This finding is funhersupported by the
invcstigationofRenkonenetal.,whichreportedmeanageofonsetofCRCof45.2inthe
Lynch Syndrome group and 53.7 in the FCCTX group (Renkonen etal.,2(03)
In2005,L1oretal. published the findings ofa prospective, population-based
cohort study including 1309 individuals recently diagnosed with CRC (L1oretal_,2005)
Only25individuals(I.9'Io)meltheACI(N-17)orACII(N~8)withI50rthese
individuals (60010) possessing MSS turnours and showing nomml MMR gene profiles
This study is significantly limited by its very small sample size of individuals with Lynch
Syndrome(N-IO)andFCCTX(N~15).Thus,anycomparisonsdmwnbelWeenthetwo
groups areofqucstionable reliability and have lowgeneralizability. Anotherlimitationof
the study isLhat mutational analysis for PMS2 was not perfonned. A recent study
reported that PMS2 mutations were responsible for approximately 9%ofMMR
deleterious variants (Hampel eta1.,2005). Despitetheselimitations,this investigation is
one of only a few prospective studies that directly compare the phenotype of Lynch
SyndromeandFCCTXandasaresultitstindingspossesssomevalue.ltsprospective
nature is a strength given the higher probability of more complete follow-upand
ascertainmcnt of outcome data relative to arctrospective design. Thepcrcentageof
family membcrs with a diagnosis ofCRC in the Lynch Syndrome and FCCTX groups
was 31.5% and 18% respectively (p <0.05). However, the authors fail to indicate exactly
how family members were defined and how many degrecs of relation were included
Despite the fact that the clinical manifestation of FCCTX appears to be Iess severe than
Lynch Syndrome, it does significantly predispose individuals to thedeve1opmentofCRC
and thus the elucidation of its genetic basis isahigh priority research pursuit
Family history cri1eria are used to stratify the a1-risk population fordeveloping
CRCandiden1ifythosewithapotentialgeneticsusccptibili1ysyndromc. Clinical criteria
for the diagnosis ofHNPCC were first established by the International Collaborative
GrouponHNPCCin 1991 during a meeting in Amsterdam (Figure 1.2).TheACloutlinc
the conditions required for a diagnosis ofHNPCC: greater than or equal 10 three relatives,
one of whom must bea first-degree relative of the other 1wo. mth CRC; the occurrence
ofCRC in at least two generations; and a1 least one diagnosis before the age of 50(Vasen
etal., 1991). TheACI were revised in 1999 to includeextra-colonic HNPCC·related
cancersundertheAmsterdamIlCriteria(ACII)(Vasenetal.,I999).lndividuals
fulfiliingeithertheACI orACll would be advised to undergo MMR mutation testing.ln
and revised in2004,identify individuals who should undergo microsatelliteinstability
(MSI) tcs1ing (Rodrigucz·Bigas et al.. 1997; Umaretal.,2004). Forpatientswhofulfill
theBethcsdaguidelincsandarefoundtohaveMSIuponinves1igation. MMR testing is
TheseguidelinesaredesignedtopredictMSlandMMRgcnemutationsas
accurately as possible. However,accordingtoa2004meta·analysis that appraised the
suitability of the ACI. ACII,andoriginal Be1hesda guidelines, they are not an exaC1
science (Kievit et al.. 2004). The results of this investigation, summarized inTablelon
thencxtpage,demonstrate1heinadequacyoftheAClandACllinpredictingthe
presence of inherited MMR deleterious variants. The results of this study should be
noma
ago 40.
Figure 1.2: The original and revised Amsterdam Criteria and BethesdaguideUnes.
Adapted from Boniselal.(2007)
Table 1.1: Reported sensitivity and specificity values (or the ACI,ACIl,andoriginal
Bethesda Guidelines to predict MM.Rgene mutations.


that ilS less invasive nature has lhe JX>tential to increase patient compJiance wilhCRC
Early screening of individuals with a family history of Lynch Syndrome,FCCTX,
high risk fordevelopingCRC, is important as it allows fora proactive, prcventive
approach to be implemented. Routine colonoscopic scrcening is also recornmendedfor
ageof25 orten ycars earlier than the age of the youngest onset ofCRC in the family
(Burke el al.. 1997; Leddinelal..2004). Follow-updecisionsarebascdonfamilyhistory



groups (hazard ratio 3.9; 95%Cl,2.3-6.7). Additionally, theconfidenceintervalsforthe
significant increase in risk ofanadverse event inthesc patients. Therefore,ee1ecoxib
appcars to possess the potential to be safely administered to low cardiovascular risk
There isa continually expanding body of evidence lhat suggeslSthat combining
caneerchemopreventive agents that possess differing mechanisms ofaction may result in
synergistic interactions that enhance thc efficacy oftrcatment (Reddy, 2(07). This
faeilitatesdosage reductions of each agent and thus diminishes the risk forlhepotentially
harmful side effects associated with the higher dosages while improving the cost-
effectiveness of the treatment. Recent studies have brought attention to thepotentiaJfor
combination therapy with acoxib and astatin to efTectively prevent the devcJopmentof
CRCinhighcardiovascularriskindividuals(Sacksetal.,I996;Xiaoetal.,2008;
Herszenyietal.,2008). The combination of an efTective phannaceuticaI intervention with
periodiccolonoscopic investigations has the potential tosignificantlyrcducetheburden
TheisiandofNewfoundlandwasdiscoveredbyGiovanniCabotoinl497,over
500 years after the establishment ofa temporary Viking scttlemcnt on theprovinee's
province was established in 1609. However, population growth was very slow because
to thirty thousand migrants essentially represent the founding population of
Newfoundland (Rahman et al., 2003). The economy of the province developed around
the lishery, resulting in senlements, known asoutports. being established almost
exclusively in coastal areas (Bear et al., 1987). The genernl trend was for families to
settle and for almost all members to marry and remain within that community. Any
migrntion that occurred tended to be to nearby settlements where resources were more
plentiful.Populationgrowthoccurredduetolargefamilysizeswhichweretypicalofthe
time. This created a process of internal proliferntion that has created genetic isolates
within the Newfoundland population. The current population of Newfoundland,
according to a 2006 Statistics Canada census, is 505,469 with approximately 60% of the
population living in communities with less than 2,500 inhabitants (StatislicsCanada,
2006). These characteristics of the Newfoundland population make it idealforstudying
particular genetic disorders that are prevalent in the population
It is possible that the higher incidence ofCRCin Newfoundland,relative to the
other Canadian provinces, is the result of founder mutations, genetic defects resulting in
susceptibility toCRC within the limited number of Irish and English immigrants that
established the population of the province (Green ct aI., 2007). This theoryspeculatesthat
gene variants conferring susceptibility to CRC were possesscd by members of the
founding population of ewfoundIand and that these variants have been passed through
the generations within the province. Renowned population geneticist Emst Mayr first
variability within isolated populations started by relatively fcwindividuals from larger
populations, which was the case in the settlement of Newfoundland (Provine, 2004}.
Mayrdescribcdthe founder effect as an example of random genetic drift, processes
whichrcsultinchangingpopulationfrequenciesofspecificalleles.lnNewfoundland,it
has been shown that a foundereffcct has resulted in higher than normal population
frequencies ofdeleterious variants causing Lynch Syndrome (Green et al., 2002}. With
the recent categorization of FCCTX, it has been theorizcd that this founderefTcctextends
to other CRC susceptibility gene variants, resulting in their higher than normal incidence.
Additionally, founderefTccts have also been demonstrated for other hereditary conditions
in Newfoundland,such as multiple endocrine neoplasia type 1(Olufemi etal..I998}and
hemophilia A (Xieetal.,2002). It is thought that there have bccn a series offounder
efTectsacross the province given the manner in which particular bays were settled by
small groups of migrants from whom the population developcd. Clearlythe founder
effect is a well-described phenomenon in Newfoundland, but it is important not to
discount the presence of some genetic heterogeneity ascommunilies werenotperfect
1.7.2 Other Populations Similar to Newfoundland
The isolated population and founderefTectswhich make Newfoundland an ideal
population for studying hereditary diseases are also attributes of other areas 0 ftheworld
and have facilitated genetic research in these centers. The popu!ation of some areas of
Quebec demonstrates the founder effect having developed with relative isolationthathas

resull of the process of recombination, which occurs at every generation shorteningthe
common regions of DNA sequence between the two lineages. Thus, it becomes easierto
identify the deleterious variant. For example, the mapping of the common MSHl
mutation rcsponsible for a significant number ofcascs of Lynch Syndrome was made
possibleonlybythegenca1ogicallinkingoftwoNewfoundlandfamiliesinhabiting
difTercntcommunities(Froggattetal.,I999).Thecurrcntstudywasplannedtofacilitate
a sequence of investigations leading to the identification of the gene(s) responsible for
CRCsusceptibility amongst individuals with FCcrx
Thefirstobjectiveofthisstudywastoidentifyfamiliesmeetingthediagnostic
criteria for FCCTX with a strong family history, defined as having at least five casesof
CRC. The second objective was to describe the clinical and pathological phenotypcofthe
FCCTX probandsand families. These features have been directly compared tocontribute
to the characterization of the clinical phenotypcofand to assess the degree of
heterogeneily prcsent within these families. The phenotype of the first-degree relatives of
the FCCTX probands were compared with first-degree relativcsoffiftccnpopulation-
based Lynch Syndrome probands in a time-to-evcnt analysis. To identifypotcntial
genetic isolales, Ihe geographic distribution of the genealogicaloriginoftheFCCTX
probands was assessed and compared to the distribution of Lynch Syndrome probands for
whomgeneticmutationshavebeenconfirmed.Thenextobjectivewastoattemptto
genealogically link as many of the FCCTX families as possible using a special ized
electronic databascand archival research. A summary of the study objectives is listed on
I. To identify FCCTXfamilieswithat least five casesofCRC from the population·based
NewfoundlandColorcctal Cancer Registry (NFCCR) and from familiesclinicallY
2. To compare the clinical and pathological phenotype of the FCCTX probandsand
3. To compare the incidenceofCRC and other outcomes in first-degree relativesof
probandsfromFCCTXandLynchSyndromefarnilies.
4. To compare the geographic origin ofFCCTX and Lynch Syndrome families
5. To determine whether any of the FCCTX families have common ancestry.
Moleculargenelics researchers initially selecled seven families (families 1-7) of
inlerestforstudyonthebasisoflheirseverephenolypeandhighpotenlialfornovelgene
discovery. These families all had at least fivecasesofCRC wilhintheirextended
pedigree, including af'fecled spouses, and fulfilled the crileria for FCCTX: meeting the
ACl,possessingnoknown MMRgenernutation.and having MSS CRC. Family I
technicaJlydoesnot fulfill theACI as the earliest diagnosisofCRC was 50 years and 2
months,whilelhecriteriaspccificallyrequireadiagnosisbeforeage50.l-Iowever. for the
purposes of this investigation. family I will be considered to fulfill the FCCTXcriteria.
as it may be very useful for novel gene discovery. An additional family (family 3) was
initially thought to meet FCCTX classification, but was later proven nottomeetlhc
required ACI. This was discovered late in the investigation and so this familyunderwent
detailed analysis. It has beenexcludcd from all analyses in the body ofthethesis, but has
becn included as an appcndix (Appendix C). Asa rcsult, six families (famil iesl,2,4,5,
6, and 7) are includcdin the body of this thcsis that undcrwentextensivegenealogicaland
Subsequently, six additional families were identified lhat met the initialinclusion
criteria: at least five family members with CRC in lhc extended pedigree with fulfillment
of the ACI. These families did not undergo the extcnsive archival research and additional
c1inicopaLhological profiling that the initial six FCCTX families weresubjcctedto,as
they were relative!y late addilions to the study. However, detailed ped igreeconstruction
was possible for these families and so they were involved in the time·to-event
comparison with the Lynch Syndrome families and the KlNNECTsoftware ana1ysis. The
investigation to twelve. Six of these families were identified in the Newfoundland
ColorectalCancerRegistry(NFCCR).apopulalion·baseddatabasecompiledof
consenting families ofpalients with pathology-<:onfirmed CRC at age less than 75
between 1999-2003 (Green et a1 .• 2007). The other six families were identified fromthe
Provincial Medical Genetics Prograrn (PMGP) having becn ascenaincdc1inically ductoa
strongfamilyhistoryofCRCbeforethetirneofthc FCCR.DifTerentiatingbetweenthe
population· and c1inic·based families is important as morc uniform follow-up andtesting
has becn pcrformed for the population·based families as they have undergone prcvious
time-to-cventsludy.Ontheotherhand.thepurelyc1inic.bascdfamiliesdid not have such
Fifteen familicswilh Lynch Syndrome were used as a comparison group forthe
FCCTX families. The Lynch Syndrome families wcrc identified fromthe NFCCR, met
the ACI orACII,and had a proband with MSI CRC and a confirmed MMRgene
mutation. Thesc particular Lynch Syndrome families were selected as theyhad
undergone previous investigation with the availability ofadatabasc eontainingfollow·up
infomlation fortime-to-eventanalyses. Flowcharts summarizing the ascenainmentoflhe
twelve FCCTX study families and fifteen Lyncb Syndrome controls are included(Figure
2.1 and Figure 2.2). The Human Investigations Comminee of the FacuhyofMedicineat




approximatc size) ofcasesofCRC. Associatcd pathology repons were reviewed and data
was systematically cxtractedusing forms (Appendix A) including all standard cancer
pathological variables according to thc College of American Pathologists (Washington et
al..2008). The variables recorded include tumour locBtion. size,histologiC type and
gmde, depth of invasion. presence of lymphatic orvascu)ar invasion. status of margins,
and occurrence ofdistant metastases. Co!onoscopyopemtive reponswere useful in that
they reported the number of polyps identified. their location, and often thcir approximate
size. Pathology reports were then analyzed in order to record the specific features of the
polyps. Data from these pathology reports was systematically extmcted using forms
(Appendix B) including all standard variables according to the College of American
PathologislS (Washington et al.. 2(08). The variables recorded include polyplocation.
type, size. configumtion. and leve) of dysplasia. The pathological datarecorded on the
cxtmctionfonnsforcolorectalpolypsandcancerwasenteredintoanSPSSdatabase for
In 1984, a quantitative family history score (FHS) measure for assessingfamilial
riskofretinoblastomawasdeveloped(Chakrabortyetal.,1984).Thepurposeof
calculating Fl-IS is to identify families with a higher than expected incidenceofa
particular disease. The FHS compares the phenotype of each first-dcgree relativeofa
proband to age and sex·matched populationcontro!s in tenns ofprobabilityofdisease
This involves comparing the observed number of cases fora family over a specific time
pcriod to the expected number of cases, calculated based on familymcmbercovariatcs
(age, sex, and race) and overall family structure. The statistic is also powered to account
The FHS calculation for estimating relative incidence ofCRC was adapted froma
1998 breast cancer study, which was based on the previously described methods proposed
by Chakroborty et al. (Yanget aI., 1998). The expected CRC incidences were calculated
using the Surveillance, Epidemiology, and End ResullS(SEER) program (National
Cancer Institute- CI).AlloftheFHScalculationswerecarriedoutusingaMicrosoft
Excel spreadsheet specifically configured to solve the equations described below. Risk
valueswerecalculatedusingperson-yearsextractcdfromdataofageatCRCorageat
last follow·up for unaffected family members. Only first-degree relatives 0 ftheprobands
were included in the calculations. The expected riskofan individualdevelopingCRC
(E,) was estimated by age, gender, and race (Caucasian, non-Hispanic) usingthe
Using the calculated expected risk values, the FHS for each fanlily was thencalculated
L) Oi) - L j E ij
T
i
= jL) E,j(l - EiJ
Oy=thcobscrved CRC status for thejth member in family i
Eu= the expected risk forCRC forthejth member in family i
SPSSversion17.0wasutilizedtoperfonnallstatisticaJanalysesdescribedinthis
section unless otherwise stated. For all teslS,thestandard signjficance level (avalue) of
CI.,,,,- ED±I.%xSE
ED-p\-p,
SE - ~'-P\("--ln~-PI"--)+-p,"--(In-~p"--,)



communities(FroggattetaJ.,I999).Thegoalofthegenealogicalinvestigation was to

This method employed by the PTRG has been was validated by genealogically
connecting Attenuated Familial Adenomatous Polyposis patients. Five patient pedigrees
information as far back as 16"'cenlury England. The genealogical research involved
as at least 500/0 of his or her siblings. This condil.ion minimized bias by allowing
flexure, and tmnsversecolon.The left colon was defincd as the splenic flexure,
descending colon, sigmoid colon. and recturn (Distler and Hoh. 1997). Polypswere
analyzed in terms of type (hyperplastic polyps or tubular, villous. and tubu!ovillous
adenomas) and location (right or left side). Tumours were analyzed in terms oflocation
(right or left side) and the occurrence ofmultlple tumours. All other variables collected
were excluded from the final anaJysis due to an unacceptable number of missing values
3.1 Comparison or Probands From Families FuIrttling the FCcrX Criteria
The clinical and pathological features of the FCCTX probands have been
summarized in the table on the following page (Table 3.1). Mean age of onset of first
primaryCRC was 56.4 and ranged from 3910 76 amongst the FCCTX probands.Ofthe
probands.six had a single left-sided CRC. four had onecasc of right-sided CRC. andrn-o
demonstrated multiple primary tumours, including both right-and left-sidedCRCs. Three
of the probands (2. 4, and 6) had the p.Val6OOGlu BRAF"ariant in their tumour DNA
with 60% of these tumours being right-sided. Intercstingly, two of these threeprobands
(probands4 and 6)expcrienced two primary tumours. However, only oneofthetw0
primary CRCsundcrwent BRAFtesting for both of these probands. The olher nine
probands had BRAFwild-typeallelesin their tumour DNA and demonstratedamarkedly
left-sided pattemoftumours, with 80% of the tumours being found distal to the
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Table 3.2: Summary of the Pearson chi square test used to compare the lwogroups.
Gender Other
Ifemales)
Lynch
S~ir
126 ~~~~~:: 52 37 41(41.2%) (29.4%) (325%)
;t :'~~~, 153 ~~ ~~::~ 56 (28.8%) 40(36.6%) (26.1%)
(~ cd)
(P'-~' (-0.110, (-0.069, (-0.101, (-0.104, (-0.043,0.126) 0.161) 0.113) -0.004) 0.171)
proponions of individuals being affected in the Lynch Syndrome group attheagesof30.
40, 50, and 60 respectively, while the percent of individuals affected roughly equalizes
later in life. The value of the log rank statistic comparing the survivalofthetwogroups
Table 3.3: Time·to-CRC outcomes for the study families and Lynch Syndrome I
popuJationgroup.
Figure 3.1: Kaplan Meier survival curvcs fortime-to-CRC for studyfamilies and the
Lynch Syndrome group.
TableJA:Time4o-.otherLynchSyndrome-relatcdcanceroutcomesforthe study
families and Lynch Syndrome population group.[ijE0hort. N Ev:nts 30 p..~~ntA~I""~~Age70 ~S~~:.I(95~RCI)F~~X 126 3 f-no------nO--"-0--;;-3--<15 • (;:E~:) 0~:~72)Lynch 94.4~iE:~:n 153 12 2 2 6 14 17 (89.8-99.I) •.
Note: Lynch Syndrome-relaled cancers included stomach. ovarian. endometrial. pancre8lic, small bowel.
Age3tLynch syndrome-R~~t.dCanCerOrL3$tFoIIOW-
Figure 3.2: Kuplan Meier survival curves fortime-to-other LynchSyndrome-related
cancer for study families aod the Lynch Syndrome group.
Table 3.5: Time·lo..<fealh oulcomes for the sludy families and LynchSyndrome
popuiationgroup.
Figure 3.3: Kaplan Meier survival curves fortime-to-dealh for study familiesand
the Lyoch Syndrome group.

+1
Figure 3.4: A map displayingtbe geograpbiclli distribution of the twelveramines
Figure3.S:AmapdisplayingthedistributionoftheLynchSyndromefamilies
~-,~~.-
I :::~,~,-".
Analyzingthctwelve FCCTXstudy families through the KINNECT software of
(see Table 3.6). In all cases, extension was JX}SSibleas far back as the earlylgti'century,
with one pedigree being extended into the early 16" century. No common ancestry
Tablc3.6:Summaryofthercsultsofgencalogicalcxtensionofthestudyfamilies'
pedigrees.
N
New Yearo(
IndividualslGenerations Recnrds
Greensoond."NL
305 1747
13 1820
35 1800
pedigrees underwent genealogical reconstruction through archival rescarch. Four of the
families(familiesJ,5,6,and7)areclinic-based,havinghadafamiIymemberreferredto
the PMGPduetoa significant family history ofCRC.The Olher two fa milies (family 2
and family 4) are populatiol1-based,having been recruited asa resu It of having a family
mcmbcrwith a case of pathology-eonfirmed CRC before the age of7S between 1999 and
2003. The average FHS for the families was 29.4. The mean ageofonset ofCRC was
59.1.Asurvival curve profiling the time-to-CRC for all six familiesi ndividuallyis
presented beJow (Figure 3.6). This figure demonstrates that the surv ivai time to CRC was
reJatively comparable amongst the six families, but thatsomedegree of heterogeneity
exislS between them. Specific findings for each of the study families are presented in the
following section. The findings that are presented in the next six sections have been
summarized and arranged in a geographical manner (fabJe 3.7).
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For the purposes of this investigation, family I (N:21)aresaidlomeet the ACI,
despiletheeartiestdiagnosisofCRCbeingatage50ratherthanbefore il.Thefamily had
a FHSof34.7 and displayed a pattem ofCRC consistent with autosomal dominant
inheritance(FigureJ.7).195newindividualswereaddedtothepedigree.whichwas
tracedbacktennewgenerationstotheearlyl~centuryinDamerham,Hampshire.
England (Appendix D). The records indicate that founding members ofthis family
migratedtoGreenspond,Newfoundlandintheeartyl~century.Thephenotypeof
family I is presented below with a profile of the polyps and tumours (fable J .8) and a
summary of the Kaplan Meier time-to-event analysis (fable J.9).The time·to-CRCdata
wasconsislent with the FCcrX phenotype, with the majority of cases occurringafterthe
ageof50.ThereweresevencolorectaltumoursandtwenlycoloreCIalpolypsreported
within the family. Polyps (71.4%) and tumours (60.0%) lended to be left-sided, while
lubularadenomas(60.0%) were the most common lypeofpolyp.The left-sided
predominance of polyps and tumours as well as the mean ageofonsel of57.9(95%CI
50.3-65.4) are consistenl with the FCcrX phenotype. However,lhethreecasesof
extra-colonicLynchSYlldrome-relatedcancersareuncharacleristicofFCcrX.The
proband had a tumour with wild-lype BRAFalleles, which incombination with the left-
sided predominance of colorectal tumours ismay besuggestiveofamolecularpathway

Croquewiththepedigreebeingextendedbacktotheearlyle;tt'centurywiththe addition


backtolhemid-18d1 centuryinGreenspond(Appendixf1.Thephenolypeoffamily4is

Table 3.12: Summary of the pbenotype of the proband and family4coIJecti"ely.
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G).Thearchivalrecordsforthisareaarequitepoorandreconstructiontotheearlylgt'
century was only made possible by the high pre-investigation qual ity of the pedigree. The
phenotype of family 5 is presented below with a profile of the polyps and tumours (fable
3.14) and a summary of the Kaplan Meier time·to-event analysis (fable3.15).This
survival analysis reported that only 10% of the family was affected withCRCbeforeme
ageof50.whichisconsistentwiththegeneraIFCCfXphenotype.Thereweresixcases
of CRC, one instance of multiple primary CRCs,and sixty-seven polyps reportedwithin
the family. Tumours (60.0%) were more commonly right-sided. while polyps (67.2%)
tended to be left-sided. The most common type of polyps identified washyperplastic
(85.1%). Mutation testing indicated that the proband had a CRC withwild-typeBRAF
alleles. These findings provide mixed evidence for the underlying molecularpathway
with the wild-type BRAFbeing atypical of the sessile serrated pathway.whiletheright·
sided predominance of tumours is more typical of this pathway.
individuals(AppendixH).Thefamilywasltacedbacktotheearlyl~century in the


Mean Age at Onset ofCRC
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penetrance (Figure 3.12). The family w3Straced back to the beginning ofthel~century

the pedigree (Appendix l}.The phenotype of family 7 is presented below wilh a profile of
thepolypsandtumours(fable3.18}anda summaryoflhe Kaplan Meiertime-to-event
analysis (fable 3.19}.This family also demonstrated the relatively lale age of onset of
CRCtypical ofFCCfX,with only 12% of individuals affected by age SO. There were
fourteen cases ofCRC, but only four with available pathology reports. 0 ne case of
multiple primary CRCs,and seven reported polyps. Polyps (85.7%) were mostcommonly
left-sided and hyperplastic, while all of the lumours with pathology reports were left-
sided.Thelefl-sidedpredominanceoftumoursandpolypsandthemeanage of onset of
CRCof60.0(9S%CI:52.1-67.9}areallconsistentwiththeFCcrXphenotype.The
two cases of extra-colonic Lynch Syndrome-related cancers areatypica1of the FCCfX
phenol'ype.Theproband was found to have CRC containing wild-l'ypeBRAFallelesand
all of the cases ofCRC within the family were left-sided.Thesefindings sUppol1 the
possibility of the involvemenl of molecular palhway other than the sessile serrated

4.1 Comparison of Probands From Families Fulfilling the FCCfXCriteria
There was significant variability in lhc clinical experience ofdisease amongst the
probandsofthe families studied meelingthe FCCTX criteria with at least five cases of
CRC. The age of onset ofCRC ranged from 39 to 76 with haJfofthe probands being
afTected before the age of60. The FHSvaJuescaleulated for the FCCTX probands ranged
from-l.3 1046.5. The variability is likely partially anribulableto the variable degreesof
screening to whieh these families have been subjected. Naturally, increased surveillanee
will lend to decrease the FHS through the prevention of cases ofCRC via colonoscopy
(Liebennan et aI., 2000). Additionally, difTerences in lifestylcare also a Iikelycontributor
tothedegreeofvariation(Longneckeretal.,I990;GiovannucciandMartincz,1996;
Sandhuetal.,2001;Noratetal.,2002).ThemainlimilationoftheFHSusage in this
context is the factLhat it is so greatly afTecled by which individual isdesignatedasthe
proband,Forexample,family7hasthefifteencascsofCRC,themoSlofalltwelve
families, but has the lowest FHS due to the fact that they wereascertained clinically and
thc first individual in the family referred 10 the PMGP had no first-degree relatives with
In lenns ofCRC location, fourprobands had a right-sided tumour, six probands
had a left-sided tumour, and two probands had boLh a righI-and left-sidedtumour.This
finding further supportsLhe heterogeneity of the FCCTX phenotype, while also
confinning the observation that tumours are mosteommonly leO-sided in individuals
under the FCCTX classification. Previous studies have reported bctween76.8%and
Three of the twelve FCCTX probandshad the p.VaJ6OOGlu BRAFvariant in their
colorectal tumour. Two of these three probands had two primary CRCs.The observation
that all three of these probands with the BRAFvariant in their tumour had cases 0 fright-
sided CRC suggests possible involvement of the sessile serrated adenoma pathway. This
pathway is thought to underlie CRCs that are more typically right-sided . demonstrate a
variable degreeofMSl,and frequently contain thep.Val6OOGlu BRAFvariant (Younget
al., 2005; Wish et al., 2010). The tumours in these probandsall hadMSS ONA,which
does not support the involvement of the sessile serrated adenoma pathway.AlIsixofthe
left-sided cases ofCRC occurred in probands with tumours containing wild-type BRAF
alleles. These tumours appear more likely to have arisen from other molecularpathways
10 CRC. The definitive association of the tumours of these probands wi Ihspecific
molecularpathwaysandepithelialarchilecturesrequiresastandardizedpathological
reviewoftumolirsandgenetictestingforKRASvarianls.Suchastandardized
pathological review is the planned subjectoffutllre research and until suchan
investigationiscomplele,theseobservationsaremerelyspecu[alion
4.2 Comparison of Study Families to Population Lynch Syndrome Group
First-degree relalivesin the FCcrX families(N = 126) demonstrated significantly
longer survival toCRC in comparison with the Lynch Syndrome group(HR=O.64,95%
Cl: 0.42-0.997). However, the lifetime risk ofCRC did not differ appreciablybetween
the groups as 47% of the study family members and 56% of the Lynch Syndromesubjects
had developed CRC by age 70. Additionally, the Pearson chi·squarecoefficientreported
no significant difference in number of cases ofCRC between the two groups (p= 0.912)
This finding is consistent with previous investigations. which similarly report a later age
2003; LindoretaJ.,2005).Asexpected.study families were also found tobeat
significantly lower risk for developing Lynch Syndrome.relatedextra-<:oloniccancer(HR
=020,95%CI: 0.06-0.72). This data supports the notion that the FCCfX phenotypeis
less severe. with significantly lateronsetofCRCand less risk of extra-colonic cancers,
than that of Lynch Syndrome. However, it does reinforce that the lifetimerisk ofCRCin
The comparison with Lynch Syndrome families is limited by the inherent
difTerences between the families in the two groups. Six of the FCCTX families were
population-based,havingbeen identified in the NFCCR, while the remainingsixFCCTX
families were ascertained clinically and identified through the PMGP. Ontheotherhand,
all fifteen of the Lynch Syndrome families utilized for comparison were population-
based,havingbcen identified in the NFCCR. Additionally, to be includedinthis
investigation. FCCTX families were required to have at least fivecascsofCRCintheir
extended pedigrce, while the same criterion was not applied to the LynchSyndrome
families. This inclusion criteria was applied in order to selcct highrisk families for novel
gene discovery andgeneaJogical reconstruction. but was not an ideal methodthrough
which toselcct families for phenotypic comparison with Lynch Syndrome families.1t
biases towards innating the number ofcases ofCRC in the FCCTX cohort, given the pre-
selection offarnilies with greater than five individuals afTected by CRC. The fact that the
first-degree relatives in the FCCTX families tended to experiencecolorectal tumOUTSata
later age remains a significant result, but the equivalence of the lifetime riskofCRC
between the groups must be called into question. The exact degree ofscreeningthateach
group was subjected to also could not be quantified for comparison in this study. The
absence of this data is a significant limitation in the comparison asdifTerencesin the
degree of screening between the groups could potentiaJly bias the resu]tsofthe anaJysis.
Given the absence of this data, the potential of screening to afTcct the number of
co)orectalrumoursdetectedandtheageatdiagnosisofthesetumourscannotbe
discounted as a confounding factor in the time·to-event ana)ysis. Another limitation of
this study is that one of the six families investigated (family I) does not actuaJlymeetthe
ACI required for the FCCTXclassificationgiventhattheearliestcaseofCRCinthe
family is at age 50 rather than before it. The difTerences in ascertainment and potentiaJ
difTerences in screening between the two groups certainly must be viewed as limitations
4.3 Geographic Distribution of FCCTX Families
The locations of origin of the Lynch Syndrome probands were widely distributed
across the recognized geographic isolates of Newfoundland, defined bythegrcatbaysof
the province. Two areas of geographical clustering have been observed that correspond
with unique MMR mutations. Individuals possessing the MSH2 deletion of exon 8
obviouslyciusterintheAvaJonPeninsula,whilcfamiliespossessingtheMSH2
p.VaI265_Gln214del variant cluster in the Bonavista Bay and Notre Dame Bay areas
(Figure 3.5). This clustering is hypothesized to be the rcsult offounderetTects whereby
members of the founding population passed these genetic variants through the generations
within these eommunities. The hypothesisofa founderetTect in FCCTX wouldsuggest
that groups of FCCTX families would be found to originate in close geographie
The twelve FCCTX probands have origins that are widely distributed aeross the
provineewith iostaneesofclustering in geographie isolates. Ofpartieularimportance in
this investigation is the geographieal clustering of probands with similar
c1inieopathologicalfeatures.Suehclusteringcouldrcsultfromaeommongenetievariant
that is predisposing these individualstoCRC. Three of the FCCTX probandsoriginated
inclose proximity in the Northern Peninsula. Two of these probands (7 and 10) from the
Northern Peninsula had a very similarclinieopathologieal phenotype,each with a left-
sided CRC whieh did not contain the p.Val600Glu BRA F variant and the abseneeof
multiple tumours. On the other hand,theother Northem Peninsula proband had a very
different phenotype having experieneed a right-sided tumourcontaining the p.Val600Glu
BRAFvarianL Proband 7 also hasmatemal lineage in theConeeption Bay area placing it
in close proximity to the origin of proband 12, who demonstrates a similarleft-sided
tUOlour with wild-type BRAFalieles. Two probands (I and 4) also originated in
Greenspond,buttheirclinicopatho!ogiealfeaturesweredrastienllyditTerenLProbandl
had a right-sided tumour with wild-type BRAFalleles, while proband 4 had multiple
CRCseontainingmutantBRAFgenes.Proband6hasrootsapproximately50kmawayin
the Hare Bay area and demonstrates an identical phenotype to proband 4 with multipIe
tumours, both right-and left-sided, eontaining the BRAFvariant with a similar age of
onsct. Outside of these areas of clustering, the FCCTX families appear to be relatively
difTusclylocatcdaroundtheprovince.Theseareasofclusteringcouldconceivably
represcnt distinct genetic etiologies of FCCTX, but based on the small number of tumours
analyzcd and the failure of the genealogical investigation to yield any commonancestTy.
The potential ofgenealogical research to connect families creating the link that
facilitates novel gene discovery is a very exciting area of research. In the past, these
studies were based entirely on tedious work by the individual. Recent technological
developments, such as the KINNECT softwarc, have automated the process to adegree
The automation of the process, which is being undertaken by the PTRG,isin its infancy
with thisscarch represcntingthe second ever use of the KINNECTsoftware. Although,
thesoftwarefailedtoyieldanydirectlinksbetweenthetwelvefamilies investigated, the
output did provide valuable infonnation in the formsofdatesofbirth,townsoforigin,
and in clarifying familial relationships. Currently, the software serves asatool to help
vcrifyinforrnationcontainedwithinpedigreesandguidefuturearchiva1 inquiries. As
the potential to quickly make genealogical links that were previously possible only by
The genealogical investigation failed to yield any common ancestry in the study
archival and on-line genealogical records. One family was traced back to the I6ltJ century,
two others to the mid-IS ltJ century, and four to the early 19111 century. The most complete
which was traced back to Damerham, England. A connection was found between these
two families, but it reprcscnted an indirect connection viaa first cousin who did not
direcdycontribute to one of the pedigrees. Two olher families were traced back to the
Northern Peninsula, while two families had roots in the Conception Baydistrict.These
families were invesligatedthoroughly for potential conneclionsgiven the fact that
migration between Conception Bay and the Northern Peninsula was common for
fishermen. After following up on numerous exciting leads and reconSlructingthe
pcdigreesas much as possible. it must be concluded that there are nodirecl genealogical
connections bctween the study families based on the available rccords. Despite the
absenceofadirectgenealogicalconnectionbetweenthesixfamilies.severalpositive
findings must be noted,Theextended pcdigreesreprcsentcomparators when other
FCCTXfamiliesinthePMGPhavetheirpcdigreesreconstructed.Theextensivemapping
of the two study families originating in Grecnspond rcpresents 8 valuablercsourceto
The absence ofcommon ancestry inthesc six FCCTX farniliessignificandy
reducestheprobabilitythatoneortwohighly-penetrantmutationsunderlie the FCCTX
wouldexpcctthcse families to share common ancestry given the extensive genealogical
reconstruction and the hypothesisofa founder effect. Common ancestry was readily
documentable in Newfoundland for families with Lynch Syndrome, which iscausedby
highly-penelIaOtmutations in MMR genes (Froggau et aI., 1999). The absence of
commonancesUyintheseFCCTXfamiliesincreasesthelikelihoodthatmultifactorial
inheritance with moderately-penetrantrnutations in mU!liplegenes provides the
etiological explanation for the classification. This would account for the failure to find
commonancesUy in the six families investigated given that tbey could polentially
represent differing combinations of the moderalely-penelIaOt genes conferring the
increased susceptibility to CRCobserved within the FCCTXclassification. Another
possibility is that these families represent chance aggregations of sporadic CRCinhigher
than normal frequency. This explanation cannot be discounted asa possibilitygiventhe
heterogeneity observed within the FCCTX classification and the reduced probabilityof
highly-penetrant genes being involved asa result of the absence of commonancestry.
The potential of genealogical research to drive genelicdiscovcriesin
Newfoundlandmustbeconsideredincontextofthefundamenlallimitationsofthe
process. The primary limitation of genealogical research is the incomplete nature of the
records. The amount of information avaiiable varies dramatically by region of the
province, with records before the 201tl century being almost entirely unavailable in some
regions. The incomplete nature of these records can be auributed toa variety of factors
the loss of records in fires, resenlement, or for other reasons; the fact that agencies
responsible for census data and population statistics did not exist inthel9tb centurywith
the responsibility being entrusted to the churches; 19tb century censuses did not include
women or children. onJy men old enough to work. Regardlcssofthe reason forthe
incompleteness of the records, it is important to note that it isa primary obstacle to the
success ofgenealogical research. Another fundamental issue is that dates of birth are
often unavailable with only baptism dates being recorded. This can make estimatingan
individuaJ's age difficult given the fact thai the age at which an individualwasbaptized
was variable. It is also very difficult to followmatemal lineages due to the frequen t
absence ofinfonnation on maiden name. Asa result,thc majority of the reconstructionin
this investigation has been through paternal lineages. In autosomal dominant inheritance.
the mutation could have been inherited from the maternal orpatemal lineage at each
generation.Thereisnohistoricalciinicalinfonnationtodetenninewhich is the relevant
iineage so the pedigree extension may not have included the correcl ancestors.This
represents a major limitation that is an inevitableconsequenceoflhe nature of the
records. There was also a significant difference in thepre.investigationquaiityofthe
pedigrees, based on the variability in famiiy members ability to trace thei rfamilytree
Another iimitation of the proccss worth noting is the unavoidable involvementofthe
subjectivity of the invesligatorin the process. The investigator is required to use logic,
intellect, and instinct in exploring potentiai genealogical eonnections, while
simultaneously investigating multiple kinships. The process allows a significantamount
ofdecisions to be made by tbe individual rather than adhering to astrict protocol. Intbis
way. genealogical research is as much an art as it isascience. One must consider Ihese
All six of the study families appear to fittbe FCCTX grouping displaying a
panern ofCRCconsistent with autosomal dominant inheritance.MSStumourONA.a
general left-sided predominance ofCRCs, and a relative absence of Lynch Syndrome-
related extra-colonic cancers. The mean age of onset ofCRC ranged from 50.8 to 63.8
between the study families and was 59.1 overaU, which confonns wilh the reported values
for the mean age of onset of53.7 and 60.7 reported in the literature (Renkonenet aI.,
The Kaplan Meicrtime-to-event analysis further reinforced lhat the study families
fulfilling the criteria conform to expected phenotype as described in the literature.There
wasonlyonccaseofCRCbcforetheageof40,lessthanorequaltoll%offamily
membcrsatTected by the age of 50, and an averageof23%alTected by age 60across all
study families. The mean time of survival to CRC ranged from 68.0 to 76. 1 amongst the
study families. Similarly. the mean of survival to the outcome death ranged from 69.3 to
77.8. These patterns arc consistent with the late-onset pattern ofCRC in the FCCTX
samplewhencomparcd to the general populationduetotheirenrollmentingenetic
databases and close follow·up. Thus, one would expect some innation in mean time to
survival figures due to theear)y detectionofco)orectal tumours that isassociatedwith
regular screening. However, this a common feature of families who are the subjectof
genetic rescarch so making comparisons between these groups is fairly valid. The
generalizabilityofthesefindingstounknownmutationcarriersinthegeneralpopulation
is more questionable. Thus, it will be important to also study this conditioninthegeneral
population once its genetic basis has been elucidated
A primary limitation of the time·to-event analysis is the mixed ascertainment of
the included families, two of whom were population-based and four of whom were c1inic-
based. In fact, all six of these families were originally discovered clinically, but two of
them werc investigated in population-based research projects having had a family
unifonn follow-up and testing has been perfonned forthepopulation-basedfamiliesas
they have undergone previoustime.to-eventstudy. On the otherhand,the purely c1inic-
bascd families did not have such uniform recording of ages at last follow·up. Despite
having been extensively followed,morethorough searching through records was
necessary to find dates ofonset ofcancer events and dates of last follow-upforthis
group. Theretrospcctive nature of the investigation means lhatagesofonsetwere
unavailableincertaincasesandsomereportedcasesofCRCinpedigreescould not bc
The pathology analysis ofcolorectal tumours and polyps from the six FCCTX
families studied in detail demonstrated a left-sided predominance of colorectaltumours
(66.7%) and polyps (66.2%). This is in agreement with previous studies that rcport
left-sided(Jassetal.,I995;L1oretal.,2005).Themostcommontypeofpolypfound
duringscreeningwasthehyperplasticpolyp(62.6%).Similartothefindingsofthe
comparison ofFCCTX probands,. the molecular mechanism underlying the development
ofCRCcould not be explained by one pathway amongst these families. There was a
mixture of left-and right-sided predominance OftUffiOUrs and the wild-type BRAFgene
andthep.Val6OOGluBRAFvariant.
A more detailed analysis of the pathological feature5 of tumours and polyps was
planned (Appendix A and Appendix B). but it was not feasible given the arnount of
missing infonnation. Asa resuh of this finding. a morefonnal evaluation of these
features is planned for the future involving the reassessment ofCRC and polyp biopsies
by a pathologist, with specific focus on the occurrcnce of serrated polyps. Giventhat the
pathology reports were analyzed in a retrospective manner, significant discrepanciesexist
Another major limitation was that many of the pathology reports were not available. The
files of the PMGPand those of geneticist Dr. Jane Green were the records that were
consulted. Thcse collections represent substantial, but incompleterecordsofthefamilies
understudy. The pathological features of significant numbers of tumours andpolypswere
unavailable as a result. Additionally, pathological investigations were not always
pcrfonned as many polyps were simply cauterized and others were snared but not
retricved. The fact that pathology reports datcd back as far as 1978 also added an
additional degree of heterogeneity to the process. Significant advancements have been
made in the field of pathology and guidelines have been altered over the last thirtyyears,
older reports. Another issue was the existence ofdiscrepancies between colonoscopy
report and pathology report on variables such as polyp location, depth ofinvasion.andthe
nature of the specimen (biopsy or intact). Despite its limi18tions, the pathologyanalysis
provides meaningful insight into the location and fearure5ofpolypsandcasesofCRC
providing valuable phenotypic information for the attempt to identify the novel
been well established by several studies{Jasselal .• 1995; Renkonen etal.,2003;Lindor
etal..2005;L1oretal.,2(05).itwouldappearappropriatetoinitiatescreeninglaterthan
the recommendations for individuals with LynchSyndrome.Thefamilyhistoryof
disease. specifically the earliest ageofonsel ofCRCin the family ,should be used to
guide lhe timing of initiating screening. The recommendations in Lynch Syndrome are to
begin screening lit age 25 orten years before the earliest age ofonse1ofCRC in the
family(Burkeetal..l997;Leddinetal.,2004).Therearenoclinicalguidelinescurrently
availllblewith screening recommendations for FCcrX. Ilseems reasonable to initiate
screeningiaterthanage25givenlheiateronsetofCRCinindividuals fulfilling the
FCCTX criteria. but formal recommendalions require further investigalion and are
oULSidelhe scope of this thesis. Advances in the area ofpharmaceulicalpreventionare
also likely in lhisarea and will warrant attention in the surveillance and prevention of
CRCinthispalientpopulation.Theobservedleft-sidedpredominanceofCRCsisalsoa
useful piece of infonnalion for physicians responsibleforcolonoscopic surveillance of
lhesepatients. Extraanention should be given to the surveillance oftheleftcolonwithout
compromising the assessment of the right colon as lumours in lhis localion occur, but less
frequendy. However, in family members of probands with BRAFdeleleriousvariantsin
their lumour, the right colon should be given particularly close surveillance given the
predominance of right·sided tumours in these individuals.
The variability in the clinicopathological features and severity ofdisease
experienced by the FCCTX probandsand family members reinforces the heterogeneity 0 f
mixed features in tennsofright·and left-sided location and tumour DNA with wild-type
andp.Val6OOGlu BRAFalleles.These mixed feat'uresprovide evidence to suggest
potential involvement of multiple molecular pathways to CRCamongst these individuals.
Theabsenceofcommonancestryinthegenealogicalinvestigationreduces the likelihood
oftheinvolvementofahighly-penetrantmutationinoneortwoundiscoveredgenes
Genetic heterogeneity is also supported by the widespread distribution of place oforigin
of probands in geographic isolates across the province. This genealogical study represents
one of the first usages of new technologies developed by the PrRG,lessonsfromwhich
will be used to improve the planning and execution offulure studies. Furthermore, the
families studied represent the beginningofa collect'ionoffully extendedpedigreesinthe
yield the direct link necessary to facilitate novel genediscovery.
The clinical experience of disease amongst first-degree relatives in the FCCTX
study families conformed to the few previously published reports in the literature. The
age ofonsct and lifetime risk ofCRC, the left-sided predominancc oftumours,andthe
relative absence of Lynch Syndrome-related cxtra-colonic cancer agreed withthe
previous reports. This study provides further evidence to the growing bodyofdata
supporting the notion that the FCCTX classification represcntsa less severe phenolypC
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AppcndixA:Forrnusedtoextrnctvariablesfrompolyppathologyreports
RecordofOtherCancer(lfyes.date) _
2.)Spct:imcnlntcgrity
_ Intact
_ Fragmented
_ Notspecified
_ Sessile serrated adenoma
_ Hamartomatouspolyp
_ NOlspecified
_ Quiescent
_Other(specify): _
AppendixB:FormusedtoextractvariablesfromCRCpathologyreports.

Family3(N=21)didnormeettheACI,rathermeetingtheBethesdaguidelines,
and therefore does not fit the FCCTX classification (Figure5.1).The proband hadMSS
CRCand the family hada FHS of3.8 and demonstr3ted a pauemofCRCconsistentwith
four new generations with the addition of 28 new individuals to Bradley's Cove in
Conception Bay as far back as the mid-18dt century (Figure 52).The phenotypeoffamily
3ispresentedbelowwithaprofileofthepolypsandtumours(fable5.1)andasummary
of the Kaplan Meiertime·to-event analysis (fable 52).The time-to-CRCdatawas
consistent with the FCcrX phenotype with theearliestcaseoccurringatage57 and a
mean age of onset of61.3 (95%CI: 54.3-682). Members of the family experieneed six
cases ofCRC, including one instance of multiple prirnary tumours. and fivecolorectal
polyps.Polyps(60.0%)andtumours(80.0%)weremorecommonlyleft-sided,while
hyperplaslicpolyps(60.0%)werethemostcommonpre-cancerouslesions identified on
cololloscopy.The proband for this family had a tumour lacking thep.Val6OOGluBRAF
variant and represents the only case of multiple primary CRCs (synchronous) in the
family. both of which were diagnosed at age 57. This family appears to represent a
pathway to CRC other than the sessile serrated adenoma pathway,given the left-sided
predominance of tumours, and the absence of the BRAFvariant in the prob.1nd'stumours
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